Loading Page
Dr. Tyler E. Reimschisel, MD is a pediatric neurologist in Cleveland, OH specializing in pediatric neurology, genetics and physician. He graduated from Rush Medical College Of Rush University in 1997 and has 29 years of experience. Dr. Tyler E. Reimschisel, MD is affiliated with University Hospitals and UH Rainbow Babies & Children's Hospital.
Dr. Tyler E. Reimschisel, MD graduated from Rush Medical College Of Rush University in 1997. He completed residency at The Johns Hopkins Children's Center. He is certified by the Clinical Biochemical Genetics - American Board of Medical Genetics and Genomics Clinical Genetics and Genomics - American Board of Medical Genetics and Genomics Neurology with Special Qualifications in Child Neurology - American Board of Psychiatry and Neurology and has a state license in Missouri.
Medical School: Rush Medical College Of Rush University (1997)
Residency: The Johns Hopkins Children's Center (1999)
Board Certification: Clinical Biochemical Genetics - American Board of Medical Genetics and Genomics Clinical Genetics and Genomics - American Board of Medical Genetics and Genomics Neurology with Special Qualifications in Child Neurology - American Board of Psychiatry and Neurology
Licensed In: Missouri
Dr. Tyler E. Reimschisel, MD does not have any reviews yet, be the first to leave a review of Dr. Tyler E. Reimschisel, MD here: Leave a Review
These charts describe general payments received by Dr. Tyler E. Reimschisel, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$19
ELAPRASE $19 |
| $19 |
Dr. Tyler E. Reimschisel, MD has received 43 research payments totaling $743,264.
Tyler Reimschisel, MD, is a pediatric neurologist and biochemical geneticist. Dr. Reimschisel’s primary clinical interests include the evaluation and management of children, adolescents and adults with inborn metabolic diseases and other genetic conditions that cause neurodevelopmental disabilities. He also provides care for pediatric patients with neurologic conditions, including developmental delay, intellectual disability, autism, seizures and headaches.
